We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

108 hedge funds and large institutions have $397M invested in Amphastar Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 32

29% more capital invested

Capital invested by funds: $307M → $397M (+$90.1M)

1.47% more ownership

Funds ownership: 43.13% → 44.61% (+1.5%)

5% less funds holding

Funds holding: 114 → 108 (-6)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

Holders
108
Holders Change
-6
Holders Change %
-5.26%
% of All Funds
2.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
32
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.77M
2
Invesco
Invesco
Georgia
+$3.51M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.5M
4
MAM
Martingale Asset Management
Massachusetts
+$1.88M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.69M

Top Sellers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
-$1.99M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.93M
3
Goldman Sachs
Goldman Sachs
New York
-$1.4M
4
Creative Planning
Creative Planning
Kansas
-$1.24M
5
Deutsche Bank
Deutsche Bank
Germany
-$865K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$2.39M – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$2.38M -$1.93M -108,242 -47%
PPA
28
Parametric Portfolio Associates
Washington
$2.23M +$963K +54,014 +87%
Allianz Asset Management
29
Allianz Asset Management
Germany
$2.13M +$258K +14,495 +15%
MAM
30
Martingale Asset Management
Massachusetts
$2.03M +$1.88M +105,629 New
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$1.69M -$26.4K -1,480 -2%
Millennium Management
32
Millennium Management
New York
$1.63M +$820K +45,986 +119%
QI
33
QS Investors
New York
$1.43M – – –
Legal & General Group
34
Legal & General Group
United Kingdom
$1.43M +$45.8K +2,568 +4%
TCIM
35
TIAA CREF Investment Management
New York
$1.42M -$92.1K -5,168 -7%
KBC Group
36
KBC Group
Belgium
$1.38M +$139K +7,782 +12%
SEI Investments
37
SEI Investments
Pennsylvania
$1.31M – – –
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.19M – – –
Prudential Financial
39
Prudential Financial
New Jersey
$1.09M -$40.5K -2,270 -4%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$1.05M -$53 -3 -0%
ASRS
41
Arizona State Retirement System
Arizona
$968K -$33.8K -1,897 -4%
BA
42
Boston Advisors
Massachusetts
$851K +$40.4K +2,268 +5%
MCM
43
Matarin Capital Management
New York
$845K -$15.2K -855 -2%
Canada Life
44
Canada Life
Manitoba, Canada
$844K – – –
VOYA Investment Management
45
VOYA Investment Management
Georgia
$768K – – –
RJA
46
Raymond James & Associates
Florida
$762K +$81.3K +4,563 +13%
Barclays
47
Barclays
United Kingdom
$733K +$353K +19,823 +108%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$729K -$85.9K -4,820 -11%
Citigroup
49
Citigroup
New York
$715K -$701K -39,320 -51%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$696K – – –
1
2
3 4 5

AMPH Hedge Fund Activity: Q3 2018 in Review

108 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2018, worth a combined $397M — up 29% from $307M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AMPH and 9 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 42 added.

The largest buyer was BlackRock, adding an estimated $4.77M. The largest seller was Fisher Asset Management, exiting entirely with an estimated $1.99M sold.

  • 108 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2018, down from 114 in Q2 2018.
  • Funds reported $397M of Amphastar Pharmaceuticals stock for Q3 2018, up 29% quarter-over-quarter.
  • 9 funds opened new Amphastar Pharmaceuticals positions in Q3 2018 and 14 closed out, a net change of -5 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2018 was BlackRock, an estimated $4.77M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2018 was Fisher Asset Management, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2018.